Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioCorRx Inc (BICX)
OTHER OTC:BICX
BioCorRx (BICX) Stock Price & Analysis
5 Followers
BICX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.66 - $2.22
Previous Close$0.78
Volume1.55K
Average Volume (3M)1.75K
Market Cap
$6.88M
Enterprise Value$8.31M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$1.57M
Price to Earnings (P/E)-1.7
Beta-0.18
Next Earnings
May 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding8,815,454
10 Day Avg. Volume1,152
30 Day Avg. Volume1,746
Standard Deviation0.23
R-Squared0.02
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.72
Price to Sales (P/S)32.16
Price to Cash Flow (P/CF)-4.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue54.32
Enterprise Value/Gross Profit38.88
Enterprise Value/Ebitda4.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioCorRx News
Options Prices
Currently, No data available
---
Ownership Overview
13.05% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
86.95% Public Companies and
Individual Investors
BICX FAQ
What was BioCorRx Inc’s price range in the past 12 months?
BioCorRx Inc lowest stock price was $0.66 and its highest was $2.22 in the past 12 months.
What is BioCorRx Inc’s market cap?
Currently, no data Available
When is BioCorRx Inc’s upcoming earnings report date?
BioCorRx Inc’s upcoming earnings report date is May 14, 2024 which is in 4 days.
How were BioCorRx Inc’s earnings last quarter?
BioCorRx Inc released its earnings results on Nov 14, 2023. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.1.
Is BioCorRx Inc overvalued?
According to Wall Street analysts BioCorRx Inc’s price is currently Overvalued.
Does BioCorRx Inc pay dividends?
BioCorRx Inc does not currently pay dividends.
What is BioCorRx Inc’s EPS estimate?
BioCorRx Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioCorRx Inc have?
BioCorRx Inc has 8,815,454 shares outstanding.
What happened to BioCorRx Inc’s price movement after its last earnings report?
BioCorRx Inc reported an EPS of -$0.1 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -18%.
Which hedge fund is a major shareholder of BioCorRx Inc?
Currently, no hedge funds are holding shares in BICX
---
BioCorRx Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.83%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-49.27%
Trailing 12-Months
Company Description
BioCorRx Inc
BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. It offers treatment philosophy that combines medical intervention and a proprietary cognitive behavioral therapy program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. It also engages in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. The company was founded by Neil Terrence Muller and George O'Neill on January 28, 2008 and is headquartered in Anaheim, CA.
---
Technical Analysis
Moleculin Biotech
―
Anavex Life Sciences
―
Benitec Biopharma
―
Zomedica Pharmaceuticals
―
---